PDGF-C Induces Maturation of Blood Vessels in a Model of Glioblastoma and Attenuates the Response to Anti-VEGF Treatment
暂无分享,去创建一个
Rakesh K. Jain | Lance L. Munn | Daniel Fuja | James Logie | R. Jain | L. Munn | W. Kamoun | J. Tyrrell | E. di Tomaso | N. London | Emmanuelle di Tomaso | James A. Tyrrell | Nyall London | Walid Kamoun | J. Logie | D. Fuja
[1] H Li,et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. , 2000, Nature cell biology.
[2] B. Elliott,et al. Localization of platelet-derived growth factor beta receptor expression in the periepithelial stroma of human breast carcinoma. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] Holger Gerhardt,et al. Endothelial-pericyte interactions in angiogenesis , 2003, Cell and Tissue Research.
[4] Ulf Eriksson,et al. Angiogenesis stimulated by PDGF‐CC, a novel member in the PDGF family, involves activation of PDGFR‐aa and ‐ap receptors , 2002 .
[5] C. Stiles,et al. Platelet alpha granules contain a growth factor for fibroblasts. , 1979, Blood.
[6] Tracy T Batchelor,et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. , 2007, Cancer cell.
[7] John Sampson,et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] R. Jain,et al. Antiangiogenic agents for the treatment of glioblastoma , 2007, Expert opinion on investigational drugs.
[9] D. George. Targeting PDGF receptors in cancer--rationales and proof of concept clinical trials. , 2003, Advances in experimental medicine and biology.
[10] G J M Parker,et al. Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Gabriele Bergers,et al. Modes of resistance to anti-angiogenic therapy , 2008, Nature Reviews Cancer.
[12] D. Louis,et al. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. , 2001, Genes & development.
[13] P. Boor,et al. PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. , 2008, Journal of the American Society of Nephrology.
[14] Badrinath Roysam,et al. Robust 3-D Modeling of Vasculature Imagery Using Superellipsoids , 2007, IEEE Transactions on Medical Imaging.
[15] M. Israel,et al. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. , 2002, Cancer research.
[16] Lei Xu,et al. Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. , 2006, Cancer research.
[17] Lei Xu,et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. , 2004, Cancer cell.
[18] David J Sugarbaker,et al. Tumorigenesis and Neoplastic Progression Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling , 2005 .
[19] R K Jain,et al. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. , 1994, Cancer research.
[20] C. Alpers,et al. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis. , 2007, Differentiation; research in biological diversity.
[21] C. Heldin,et al. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[22] F. Peale,et al. Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor α Signaling Is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung Carcinoma , 2006, Clinical Cancer Research.
[23] T. Kanda,et al. Peripheral Nerve pericytes originating from the blood–nerve barrier expresses tight junctional molecules and transporters as barrier‐forming cells , 2008, Journal of cellular physiology.
[24] J. Rastad,et al. Expression of platelet-derived growth factor beta-receptors on stromal tissue cells in human carcinoid tumors. , 1990, Cancer research.
[25] P. Black,et al. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. , 2000, Cancer research.
[26] I. Kasman,et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. , 2009, Cancer cell.
[27] C. Heldin,et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. , 2001, Nature cell biology.
[28] Ulf Eriksson,et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke , 2008, Nature Medicine.
[29] Dai Fukumura,et al. Dissecting tumour pathophysiology using intravital microscopy , 2002, Nature Reviews Cancer.
[30] J. Rothberg,et al. PDGF-D, a new protease-activated growth factor , 2001, Nature Cell Biology.
[31] C. Betsholtz,et al. Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts. , 2009, Cancer research.
[32] Rakesh K Jain,et al. Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers. , 2005, Cancer research.
[33] C. Heldin,et al. Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.
[34] A. Gregory Sorensen,et al. Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.
[35] C. James,et al. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas , 2001, Neurology.
[36] T. Kawai,et al. Expression in lung carcinomas of platelet-derived growth factor and its receptors. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[37] Xuri Li,et al. Novel PDGF family members: PDGF-C and PDGF-D. , 2003, Cytokine & growth factor reviews.
[38] R. Jain,et al. Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] Ulf Eriksson,et al. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] R. Jain,et al. Targeting PDGF Signaling in Carcinoma-Associated Fibroblasts Controls Cervical Cancer in Mouse Model , 2008, PLoS medicine.
[41] D. Bowen-Pope,et al. Production of platelet‐derived growth factor by cultured Wilms' tumor cells and fetal kidney cells , 1987, Journal of cellular physiology.
[42] R. Carroll,et al. Expression of platelet-derived growth factor transcripts in medulloblastomas and ependymomas. , 1996, Pediatric neurosurgery.